Pitts T O, Van Thiel D H
Recent Dev Alcohol. 1986;4:379-440. doi: 10.1007/978-1-4899-1695-2_17.
This chapter critically reviews our current understanding of the pathogenesis, clinical syndrome, and therapy of the disturbances of renal sodium handling, renal perfusion, and glomerular filtration rate that occur in patients with Laennec's cirrhosis. Avid renal sodium reabsorption, a characteristic feature of cirrhosis, occurs independent of moderate changes in renal function and precedes the onset of ascites. The initiation of sodium retention may be a direct consequence of the hepatic disease process and may also result from defective intravascular filling. In the presence of ascites the most important sodium retaining signal is a defective intravascular volume. The principal effectors of renal sodium retention and vasoconstriction are stimulation of the renin-angiotensin-aldosterone axis and augmentation of renal sympathetic nerve activity. Deficient production of natriuretic hormone(s) and endogenous renal vasodilators, such as prostaglandins and kinins, also contributes to the sodium retention and renal hypoperfusion seen in cirrhosis. The hepatorenal syndrome is an extreme imbalance in these renal vasoconstrictor and vasodilator forces. In the therapy of ascites in Laennec's cirrhosis, abstention from alcohol, sodium restriction, and cautious diuresis are the principal therapeutic measures. A grave prognosis accompanies the diagnosis of the hepatorenal syndrome although recoveries have been reported.
本章批判性地回顾了我们目前对发生在Laennec肝硬化患者中的肾钠处理、肾灌注及肾小球滤过率紊乱的发病机制、临床综合征和治疗的理解。肾钠重吸收增加是肝硬化的一个特征性表现,其发生与肾功能的中度改变无关,且先于腹水出现。钠潴留的起始可能是肝脏疾病过程的直接后果,也可能源于血管内充盈缺陷。在腹水存在的情况下,最重要的钠潴留信号是血管内容量不足。肾钠潴留和血管收缩的主要效应器是肾素-血管紧张素-醛固酮轴的激活及肾交感神经活性增强。利钠激素和内源性肾血管扩张剂(如前列腺素和激肽)产生不足也促成了肝硬化时出现的钠潴留和肾灌注不足。肝肾综合征是这些肾血管收缩和扩张力量的极端失衡。在Laennec肝硬化腹水的治疗中,戒酒、限钠和谨慎利尿是主要治疗措施。尽管有恢复的报道,但肝肾综合征的诊断预示着严重的预后。